Материалы

05.08.2020

Role of Plasma Presepsin, Procalcitonin and C-reactive Protein Levels in Determining the Severity and Mortality of Community-Acquired Pneumonia in the Emergency Department

Izzettin Hur1, Seda Ozkan2;*, Ali Halici3, Kerim Abatay4,
Eren Usul5, Esra Cetin6, Fevzi Nuri Aydin6

1Department of Emergency Medicine,
Ministry of Health Pursaklar State
Hospital, Ankara, Turkey
2Department of Emergency Medicine,
Cerrahpasa Faculty of Medicine, Istanbul
University-Cerrahpasa, Istanbul, Turkey
3Department of Emergency Medicine,
Ministry of Health Polatlı State Hospital,
Ankara, Turkey
4Department of Emergency Medicine,
Ministry of Health Muş State Hospital,
Muş, Turkey
5Department of Emergency Medicine,
Ministry of Health Dr. Nafiz Korez Sincan
State Hospital, Ankara, Turkey
6Department of Clinical Biochemistry,
Diskapi Yildirim Beyazit Training &
Research Hospital, Ankara, Turkey
*Correspondence
sedacil@gmail.com
(Seda Ozkan)
28.04.2020

Роль пресепсина в диагностике и оценке тяжести течения сепсиса и тяжелой пневмонии

Е.А. Титова 1) А.Р. Эйрих 2) З.А. Титова 3)

1) ФГБОУ ВО "Алтайский государственный медицинский университет"
2) КГБУЗ "Краевая клиническая больница", Барнаул, Россия
28.04.2020

Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia

Zhi-jiang Qia,1, Han Yua,1, Jing Zhangb, Chun-sheng Lia,⁎
a Emergency Department of Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
b Emergency Department of Beijing Tuberculosis Research Institute, Capital Medical University, Beijing 101149, China
28.04.2020

PRESEPSIN AND PROCALCITONIN – MARKERS OF SEPSIS AND SEVERE PNEUMONIA

1Altai State Medical University, Barnaul
2Regional Clinical Hospital, Barnaul
Ye.A. Titova1, Ye.M. Reutskaya2, Z.A. Titova1, S.I. Kytmanova2, Ye.M. Petayeva2, A.R. Eirikh2
28.04.2020

Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia

Motoi Ugajin1, Yu Matsuura2, Kei Matsuura2, Hiroshi Matsuura2
1Department of Respiratory Medicine, 2Department of Internal Medicine, Nagoya Tokushukai General Hospital, Kasugai City, Aichi Prefecture,
Japan
Contributions: (I) Conception and design: M Ugajin; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors;
(IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: M Ugajin; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Motoi Ugajin, MD. Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai
City 487-0016, Japan. Email: ugarin2001@yahoo.co.jp.
28.04.2020

A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores

Ji Yeon Ham, MD, Kyung Eun Song, MD, PhD*
Laboratory Medicine 2019;XX:0–0
DOI: 10.1093/labmed/lmz005
28.04.2020

Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department

Emergency Department, Beijing Chao-Yang Hospital of the Capital Medical University,
Beijing 100020, China
Received 29 January 2014; accepted 6 May 2014
Available online 2 June 2014
28.04.2020

Impact of initial plasma presepsin level for clinical outcome in hospitalized patients with pneumonia

Motoi Ugajin1, Yu Matsuura2, Kei Matsuura2, Hiroshi Matsuura2
1Department of Respiratory Medicine, 2Department of Internal Medicine, Nagoya Tokushukai General Hospital, Kasugai City, Aichi Prefecture,
Japan
Contributions: (I) Conception and design: M Ugajin; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors;
(IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: M Ugajin; (VI) Manuscript writing: All authors; (VII) Final
approval of manuscript: All authors.
Correspondence to: Motoi Ugajin, MD. Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho Kita, Kasugai
City 487-0016, Japan. Email: ugarin2001@yahoo.co.jp.
28.04.2020

The role of presepsin in the diagnosis of chronic obstructive pulmonary disease acute exacerbation with pneumonia

Ali Halıcı1, I˙zzettin Hu¨ r1, Kerim Abatay1, Esra C¸ etin2, Filiz Halıcı3 & Seda O¨ zkan*,4
1Department of Emergency Medicine, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital,
06145, Ankara, Turkey
2Department of Biochemistry, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital, 06145, Ankara,
Turkey
3Department of Family Medicine, University of Health Sciences, Diskapi Yildirim Beyazit Training & Research Hospital,
06145, Ankara, Turkey
4Department of Emergency Medicine, University of Istanbul-Cerrahpasa, Faculty of Medical, 34098, Istanbul, Turkey
*Author for correspondence: Tel.: +90 212 414 3434; sedacil@gmail.com
03.07.2019

Change in the presepsin level in hemodialysis patients with pneumonia and sepsis

1 Altai State Medical University, Barnaul
2 Regional Clinical Hospital, Barnaul
E.A. Titova1, A.R. Eirikh2, Z.A. Titova1, O.G. Zhgut2, S.I. Ivanova2, T.N. Zateeva2, D.V. Petrova2, E.M.
Reutskaya2
03.12.2018

Роль пресепсина в диагностике и оценке тяжести течения сепсиса и тяжелой пневмонии

Е.А. Титова 1, А.Р. Эйрих 2, З.А. Титова , Терапевтический архив . 2018; 11: 44-47
11.09.2017

Пресепсин – маркер сепсиса и тяжелой пневмонии

Титова Е.А., Реуцкая Е.М., Эйрих А.Р.
Пульмонология. 2017;27(3):366-370.
12.07.2016

Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community‑acquired pneumonia in ICU patients

Kada Klouche1,2* , Jean Paul Cristol2,3, Julie Devin3, Vincent Gilles1, Nils Kuster3, Romaric Larcher1,
Laurent Amigues1, Philippe Corne1, Olivier Jonquet1 and Anne Marie Dupuy3

Яндекс.Метрика